Interaction of annexins with membrane skeletal proteins in brain
膜联蛋白与大脑中膜骨骼蛋白的相互作用
基本信息
- 批准号:05680676
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To elucidate the physiological significance of annexin VI in brain, we developed a method to detect annexin VI-binding proteins using ^<125>I-annexin VI on a nitrocellulose sheet to which rat brain proteins were electrophoretically transferred after SDS polyacrylamide gel electrophoresis. When we anlayzed the wohole homogenate of rat brain cortex, significant binding of annexin VI was observed at the protein bands of Mr450K,350K,240K,180K,120-140K,105K,80K,63K,48K,32K,27K,23K and 16K.The binding was dependent on Ca^<2+> and phosphatidylserine (PS) or phosphatidic acid. No significant binding was observed with phosphatidylcholine, phosphatidylethanolamine, or phosphatidylinositol.A line of evidences indicated that the binding is a direct protein-protein interaction between annexin VI and its binding proteins. Of annexin VI-binding proteins, the 80K and the 240K proteins were identified to be synapsin I and calspectin, respectively. The bindings of annexin VI to these proteins were also observed in the native state. Annexin VI bound to the NH2-terminal head region of synapsin I.The binding was inhibited by phosphorylation of synapsin I by cAMP-PK or by CaM-PK II.Annexin VI inhibited the interaction between calspectin and Factin by binding to calspectin in the presence of Ca^<2+> and PS,indicating a regulatory role of annexin VI in the modulation of membrane skeleton by Ca^<2+>. Thus, the methods used here were proven to be quite powerful in identifying the molecular targets of annexin VI.The physiological roles of annexin VI in brain can be elucidated by examining the effects of annexin VI on its targets.
为了阐明膜联蛋白VI在脑中的生理意义,我们开发了一种方法,检测膜联蛋白VI结合蛋白使用^<125>I-膜联蛋白VI的硝酸纤维素片,大鼠脑蛋白在SDS聚丙烯酰胺凝胶电泳后,电泳转移。对大鼠脑组织匀浆进行分析时,在Mr 450 K、350 K、240 K、180 K、120- 140 K、105 K、80 K、63 K、48 K、32 K、27 K、23 K和16 K蛋白带处观察到膜联蛋白VI的显著结合,这种结合依赖于Ca^<2+>和磷脂酰丝氨酸(PS)或磷脂酸。膜联蛋白VI与磷脂酰胆碱、磷脂酰乙醇胺和磷脂酰肌醇的结合均不明显,表明膜联蛋白VI与其结合蛋白的结合是一种直接的蛋白质-蛋白质相互作用。在膜联蛋白VI结合蛋白中,80 K和240 K蛋白分别被鉴定为突触蛋白I和钙网蛋白。在天然状态下也观察到膜联蛋白VI与这些蛋白质的结合。Annexin VI与突触蛋白I的NH 2端头部区域结合,这种结合被cAMP-PK或CaM-PK II磷酸化的突触蛋白I所抑制。在Ca^2+和PS存在的情况下,Annexin VI通过与calspectin结合来抑制calspectin和Factin之间的相互作用,表明Annexin VI在Ca^2+调节膜骨架中起调节作用。因此,这里使用的方法被证明是相当强大的识别膜联蛋白VI的分子靶点。膜联蛋白VI在脑中的生理作用可以通过检查膜联蛋白VI对其靶点的影响来阐明。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inui,M.: "Annexin VI binds to a synaptic vesicle protein,synapsin I." J.Neurochem.63. 1917-1923 (1994)
Inui,M.:“Annexin VI 与突触小泡蛋白突触蛋白 I 结合。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Watanabe,T.: "Annexin VI-binding proteins in brain.Interaction of annexin VI with a membrane skeletal proteins.calspectin(brain spectrin or fodrin)." J.Biol.Chem.269. 17656-17662 (1994)
Watanabe,T.:“大脑中的膜联蛋白 VI 结合蛋白。膜联蛋白 VI 与膜骨骼蛋白的相互作用。钙观蛋白(脑血影蛋白或胞质蛋白)。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inui,M.: "Annexin VI-binding proteins in brain.In Neuronal Cystoskeleton." CRC Press, 355 (1993)
Inui,M.:“大脑中的膜联蛋白 VI 结合蛋白。在神经元细胞骨架中。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Watanbe, T.: "Annexin VI-bingding proteins in brain : Interaction of annexin VI with a membrane skeletal protein, calspectin (brain spectrin or fodrin)." J.Biol.Chem.269. 17656-17662 (1994)
Watanbe, T.:“大脑中的膜联蛋白 VI 结合蛋白:膜联蛋白 VI 与膜骨骼蛋白钙观蛋白(脑血影蛋白或胞质蛋白)的相互作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inui,M.: "Annexin VI binds to a synaptic vesicle protein,synapsin I." J.Neurochem.(in press). (1994)
Inui,M.:“Annexin VI 与突触小泡蛋白突触蛋白 I 结合。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
INUI Makoto其他文献
INUI Makoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('INUI Makoto', 18)}}的其他基金
Ultrastructural analysis of calcium transport system of cardiac sarcoplasmic reticulum for drug development
心脏肌浆网钙转运系统的超微结构分析用于药物开发
- 批准号:
17H04033 - 财政年份:2017
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the molecular mechanisms by a cyclic peptide, SEK-1005 promotes skin wound healing
阐明环肽 SEK-1005 促进皮肤伤口愈合的分子机制
- 批准号:
16K15203 - 财政年份:2016
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of IGF-1 receptor-independent signaling from IGF-1 and its application for drug development
IGF-1 的 IGF-1 受体非依赖性信号传导分析及其在药物开发中的应用
- 批准号:
25670128 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of a new drug for heart failure targeting phospholamban
以受磷蛋白为靶点的心力衰竭新药的开发
- 批准号:
25293062 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel inotropic and lucitorpic agent for treatment of heart failure
开发用于治疗心力衰竭的新型正性肌力药物和促光亮药物
- 批准号:
22390050 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a new drug for heart failure
开发治疗心力衰竭的新药
- 批准号:
14370032 - 财政年份:2002
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of ion channel regulation by a protein-protein interaction
蛋白质-蛋白质相互作用调节离子通道的分子机制
- 批准号:
12470019 - 财政年份:2000
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of cytoskeleton by annexin VI
膜联蛋白 VI 对细胞骨架的调节
- 批准号:
07680842 - 财政年份:1995
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interaction between ion channels and membrane skeleton
离子通道与膜骨架之间的相互作用
- 批准号:
03833019 - 财政年份:1991
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Role of altered endoplasmic reticulum calcium regulation and the N-methyl-D-aspartate (NMDA) receptor signaling in cortico-striatal synaptic dysfunction: Opportunities for therapy in prodromal Huntington disease
改变的内质网钙调节和 N-甲基-D-天冬氨酸 (NMDA) 受体信号在皮质纹状体突触功能障碍中的作用:前驱期亨廷顿病的治疗机会
- 批准号:
443591 - 财政年份:2021
- 资助金额:
$ 1.28万 - 项目类别:
Operating Grants
Molecular mechanism and physiological function of mitochondrial calcium regulation
线粒体钙调节的分子机制及生理功能
- 批准号:
10455701 - 财政年份:2020
- 资助金额:
$ 1.28万 - 项目类别:
Molecular mechanism and physiological function of mitochondrial calcium regulation
线粒体钙调节的分子机制及生理功能
- 批准号:
10192800 - 财政年份:2020
- 资助金额:
$ 1.28万 - 项目类别:
N-terminomics/proteomics investigation of calpain-1 and -2 substrates during calcium regulation
钙调节过程中 calpain-1 和 -2 底物的 N 末端组学/蛋白质组学研究
- 批准号:
552792-2020 - 财政年份:2020
- 资助金额:
$ 1.28万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Molecular mechanism and physiological function of mitochondrial calcium regulation
线粒体钙调节的分子机制及生理功能
- 批准号:
9370196 - 财政年份:2020
- 资助金额:
$ 1.28万 - 项目类别:
Calcium Regulation in Heart Failure with Preserved versus Reduced Ejection Fraction
保留射血分数与降低射血分数的心力衰竭中的钙调节
- 批准号:
10161855 - 财政年份:2019
- 资助金额:
$ 1.28万 - 项目类别:
Calcium Regulation in Heart Failure with Preserved versus Reduced Ejection Fraction
保留射血分数与降低射血分数的心力衰竭中的钙调节
- 批准号:
9978114 - 财政年份:2019
- 资助金额:
$ 1.28万 - 项目类别:
Calcium Regulation in Heart Failure with Preserved versus Reduced Ejection Fraction
保留射血分数与降低射血分数的心力衰竭中的钙调节
- 批准号:
10425343 - 财政年份:2019
- 资助金额:
$ 1.28万 - 项目类别:
Calcium-regulation of nuclear proteins involved in stress tolerance
参与应激耐受的核蛋白的钙调节
- 批准号:
1908125 - 财政年份:2017
- 资助金额:
$ 1.28万 - 项目类别:
Studentship
Nuclear calcium regulation of plant development
植物发育的核钙调节
- 批准号:
BB/P007112/1 - 财政年份:2017
- 资助金额:
$ 1.28万 - 项目类别:
Fellowship














{{item.name}}会员




